Vitrectomy and Subretinal Injection of Tissue Plasminogen Activator for Large Submacular Hemorrhage Secondary to AMD
Vitrectomy and Subretinal Injection of Tissue Plasminogen Activator for Large Submacular Hemorrhage Secondary to AMD
复制标题
玻璃体切除术和视网膜下注射组织纤溶酶原激活剂治疗 AMD 继发的大黄斑下出血
DOI:
10.5301/ejo.5000500
复制
发表时间:
2014
影响因子:
1.7
通讯作者:
A. Barak
中科院分区:
文献类型:
--
作者:
E. Moisseiev;Tal Ben Ami;A. Barak
Purpose To evaluate the efficacy and safety of pars plana vitrectomy (PPV) with subretinal injection of tissue plasminogen activator (tPA) for the treatment of large submacular hemorrhage (SMH) secondary to age-related macular degeneration (AMD), and identify parameters correlated with the visual prognosis. Methods Thirty-one eyes that underwent PPV with subretinal tPA injection for large SMH secondary to AMD were included in this retrospective study. Main outcome measure was improvement in at least one line in visual acuity (VA). Results Improvement in VA was achieved in 14 (45.2%) patients. These patients had a significantly worse VA at presentation than patients who did not improve (p = 0.05). Central retinal thickness and earlier intervention were not correlated with the final visual prognosis. Postoperative complications included retinal detachment (19.3%), recurrent SMH (6.4%), and elevated intraocular pressure (6.4%). Conclusions The VA at presentation is the most significant pre-operative parameter associated with improvement in VA. A cutoff value of counting fingers VA is suggested, as patients with better VA at presentation did not benefit from surgery.
影响因子:
4.2
作者:
GLATT, H;MACHEMER, R
通讯作者:
MACHEMER, R
影响因子:
13.7
作者:
Bressler, NM;Bressler, SB;Williams, GA
通讯作者:
Williams, GA
影响因子:
13.7
作者:
Childs, AL;Bressler, NM;Miskala, PH
通讯作者:
Miskala, PH